Quel est le prix pour Vitrolife AB (publ) (VITR)

Le prix pour Vitrolife AB (publ) (VITR) est $10.67

Quelle est la capitalisation boursière pour Vitrolife AB (publ) (VITR)

La capitalisation boursière pour Vitrolife AB (publ) (VITR) est $1.44B

Bénéfices de Vitrolife AB (publ) (VITR)

Vitrolife AB (publ) is a medical technology company specializing in the development, production, and global sale of products for assisted reproduction. Their comprehensive offering includes a variety of essential tools for fertility treatments, such as oocyte retrieval needles, sperm processing solutions, specialized in vitro fertilization media and oils, and micromanipulation pipettes. The company also provides general labware, incubators, cryopreservation products, and systems for preimplantation genetic testing. Furthermore, Vitrolife delivers advanced equipment, including the EmbryoScope and Primo Vision time-lapse systems, along with dedicated dishes and evaluation software for these platforms. Their technology portfolio extends to Octax laser and imaging systems, as well as environmental monitoring solutions like log and guard systems and wireless sensors. With its headquarters located in Gothenburg, Sweden, Vitrolife maintains a significant international presence, operating across Europe, the Middle East, and Africa; Asia; Japan and the Pacific; and both North and South America. Founded in 1994, the company was initially known as Scandinavian IVF Science before officially changing its name to Vitrolife AB (publ) in 1998.

Année	Bénéfices	Changez
Pas assez de données pour les dates fournies.

Année

Bénéfices

Changez

Pas assez de données pour les dates fournies.

Entreprise	Bénéfices	Différence de bénéfices	Pays
Abbott Laboratories ABT.US	$7.51B	-	US
Stryker Corporation SYK.US	$5.15B	-	US
Medtronic plc MDT.US	$5.56B	-	IE
Boston Scientific Corporation BSX.US	$3.86B	-	US
Siemens Healthineers AG SHL.DE	-	-	DE

Entreprise

Bénéfices

Différence de bénéfices

Pays